RotaTeq is fully liquid and ready to use, so it can be easily incorporated into the childhood immunization schedule. Each dosing tube includes 2 peel-off labels for use in record keeping.
View an animation of dosage and administration guide for RotaTeq below.
The safety and efficacy of RotaTeq® (Rotavirus Vaccine, Live, Oral, Pentavalent) have not been established in infants younger than 6 weeks of age or older than 32 weeks of age.
RotaTeq: Convenient Scheduling
The vaccination series consists of three ready-to-use liquid doses administered orally for RotaTeq starting at 6 to 12 weeks of age, with the subsequent doses administered at 4- to 10-week intervals. The third dose should not be given after 32 weeks of age.
RotaTeq: A Sample Schedule
Doses
Age at 1st dose
Interval
A sample schedule
3
6–12 weeks of age
4–10 weeks apart
2, 4, and 6 months of age
•
There are no restrictions on the infant's consumption of food or liquid, including breast milk, either before or after vaccination with RotaTeq.
•
In clinical trials, RotaTeq was routinely administered concomitantly with diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus vaccine (IPV), H influenzae type b conjugate vaccine (Hib), hepatitis B vaccine, and pneumococcal conjugate vaccine.
There was no evidence for reduced antibody responses to diphtheria or tetanus toxoid components of DTaP or to other vaccines that were concomitantly administered with RotaTeq. However, insufficient immunogenicity data are available to confirm lack of interference of immune responses when RotaTeq is concomitantly administered with childhood vaccines to prevent pertussis.
•
If for any reason an incomplete dose of RotaTeq is administered (eg, infant spits or regurgitates the vaccine), a replacement dose is not recommended, because such dosing was not studied in the clinical trials. The infant should continue to receive any remaining doses in the recommended series.
RotaTeq: Easy Storage
RotaTeq is refrigerator stable at 2°C to 8°C (36°F to 46°F). It should be administered as soon as possible after being removed from refrigeration. For information regarding stability under conditions other than those recommended, call 1-800-MERCK-90 (1-800-637-2590).
This site is intended only for healthcare professionals
of the United States, its territories, and Puerto Rico.
RotaTeq is a registered trademark of Merck & Co., Inc.
20750348(4)-11/07-RTQ
